Interleukin-1 (IL-1) alpha, beta, IL-1 receptor (IL-1R) , IL-1 receptor antagonist (IL-1ra)
Hayashi, H.; Onozaki, K.
Nihon Rinsho. Japanese Journal of Clinical Medicine 68(Suppl 7): 62-66
2010
ISSN/ISBN: 0047-1852 PMID: 20960750 Document Number: 646520
Document emailed within 1 workday
Related Documents
Hayashi, H.; Onozaki, K. 2005: Interleukin-1 (IL-1) alpha, beta, IL-1 receptor, IL-1 receptor antagonist (IL-1ra) Nihon Rinsho. Japanese Journal of Clinical Medicine 63(Suppl 8): 60-64Ohtsuka, K.; Yasunami, Y.; Ikehara, Y.; Nagai, T.; Kodama, S.; Maki, T.; Tomita, A.; Abo, T.; Ikeda, S. 1997: Expansion of intermediate T cell receptor cells expressing interleukin-2 receptor alpha- beta+, CD8alpha+ beta+, and lymphocyte function-associated antigen-1+ in the liver in association with intrahepatic islet xenograft rejection from rat to mouse: prevention of rejection with anti-interleukin-2 receptor beta monoclonal antibody treatment Transplantation 64(4): 633-639
Fleishmann, R.M. 2002: Safety of anakinra, a recombinant interleukin-1 receptor antagonist (r-metHuIL-1ra), in patients with rheumatoid arthritis and comparison to anti-TNF-alpha agents Clinical and Experimental Rheumatology 20(5 Suppl 27: S35-S41
Arman, A.; Yilmaz, B.; Coker, A.; Inanc, N.; Direskeneli, H. 2006: Interleukin-1 receptor antagonist (IL-1RN) and interleukin-1B gene polymorphisms in Turkish patients with rheumatoid arthritis Clinical and Experimental Rheumatology 24(6): 643-648
Sims, J.E.; Smith, D.E. 2003: Regulation of interleukin-1 activity is enhanced by cooperation between the interleukin-1 receptor type Ii and interleukin-1 receptor accessory protein European Cytokine Network 14(2): 77-81
Takahama, Y.; Kosugi, A.; Singer, A. 1991: Phenotype, ontogeny, and repertoire of CD4-CD8- T cell receptor alpha beta + thymocytes. Variable influence of self-antigens on T cell receptor V beta usage Journal of Immunology 146(4): 1134-1141
Barillé, S.; Bataille, R.; Amiot, M. 2000: The role of interleukin-6 and interleukin-6/interleukin-6 receptor-alpha complex in the pathogenesis of multiple myeloma European Cytokine Network 11(4): 546-551
Ennis, C.; Cox, B. 1980: The dopamine receptor antagonist domperidone is also a competitive antagonist at alpha 1-adrenoceptors Journal of Pharmacy and Pharmacology 32(6): 434-435
Chen, Z.; Colon, I.; Ortiz, N.; Callister, M.; Dong, G.; Pegram, M.Y.; Arosarena, O.; Strome, S.; Nicholson, J.C.; Van Waes, C. 1998: Effects of interleukin-1alpha, interleukin-1 receptor antagonist, and neutralizing antibody on proinflammatory cytokine expression by human squamous cell carcinoma lines Cancer Research 58(16): 3668-3676
Pacifici, R.; Roman, J.; Kimble, R.; Civitelli, R.; Brownfield, C.M.; Bizzarri, C. 1994: Ligand binding to monocyte alpha 5 beta 1 integrin activates the alpha 2 beta 1 receptor via the alpha 5 subunit cytoplasmic domain and protein kinase C Journal of Immunology 153(5): 2222-2233
Krishnan, B.R. 1999: Interleukin-1 receptor antagonist gene therapy for arthritis Current Opinion in Molecular Therapeutics 1(4): 454-457
Gabay, C.; Porter, B.; Fantuzzi, G.; Arend, W.P. 1998: Mouse IL-1 receptor antagonist isoforms: complementary DNA cloning and protein expression of intracellular isoform and tissue distribution of secreted and intracellular IL-1 receptor antagonist in vivo Journal of Immunology 159(12): 5905-5913
Déage, V.; Burger, D.; Dayer, J.M. 1998: Exposure of T lymphocytes to leflunomide but not to dexamethasone favors the production by monocytic cells of interleukin-1 receptor antagonist and the tissue-inhibitor of metalloproteinases-1 over that of interleukin-1beta and metalloproteinases European Cytokine Network 9(4): 663-668
Karrer, U.; Aeschlimann, A.; Fassbender, K.; Vogt, P.; Müller, W. 1992: Interleukin-6 (IL-6), soluble interleukin-2-receptor (sIL-2R) and microheterogeneity of alpha-! acid glycoprotein (AGP): new markers of the acute-phase reaction? Schweizerische Medizinische Wochenschrift 122(7): 233-236
Wang, Q.; Zhan, F.-x.; Shan, N.-n.; Hou, M.; Yang, X.-j.; Lu, N.; Wang, H.-c.; Zhang, X.-l.; Ji, X.-b.; Ji, C.-y. 2010: Expression of interleukin-18 and interleukin-18 receptor alpha chain of the peripheral white blood cells in immune thrombocytopenia Zhonghua Nei Ke Za Zhi 49(4): 316-319
Kotula-Balak, M.; Gancarczyk, M.; Sadowska, J.; Bilinskai, B. 2005: The expression of aromatase, estrogen receptor alpha and estrogen receptor beta in mouse Leydig cells in vitro that derived from cryptorchid males European Journal of Histochemistry: Ejh 49(1): 59-62
Boermeester, M.A.; van Leeuwen, P.A.; Schneider, A.J.; Houdijk, A.P.; Ferwerda, C.C.; Wesdorp, R.I. 1993: Interleukin-1 receptor antagonist: a new therapeutic agent in the treatment of sepsis syndrome Nederlands Tijdschrift Voor Geneeskunde 137(7): 337-342
Lo, S.F.; Huang, C.M.; Tsai, C.H.; Chen, M.L.; Tsai, F.J. 2005: Interleukin-1 receptor antagonist gene polymorphism in Taiwanese patients with gout Clinical and Experimental Rheumatology 23(1): 85-88
Ma, T.; Miyanishi, K.; Trindade, M.C.D.; Genovese, M.; Regula, D.; Smith, R.L.; Goodman, S.B. 2003: Interleukin 1 receptor antagonist inhibits localized bone formation in vivo Journal of Rheumatology 30(12): 2547-2552
Arend, W.P.; Malyak, M.; Smith, M.F.; Whisenand, T.D.; Slack, J.L.; Sims, J.E.; Giri, J.G.; Dower, S.K. 1994: Binding of IL-1 alpha, IL-1 beta, and IL-1 receptor antagonist by soluble IL-1 receptors and levels of soluble IL-1 receptors in synovial fluids Journal of Immunology 153(10): 4766-4774